Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Secretin · Chirhostim, Secretin-Ferring

Recombinant protein · Agonist of Secretin receptor · developed by Ferring

Approved FDA
2 Registered trials

What is Secretin?

Secretin is a 27-amino-acid peptide hormone that binds secretin receptors on pancreatic duct cells, opening CFTR channels and driving bicarbonate-rich pancreatic fluid secretion. It is used to stimulate pancreatic secretions for diagnostic testing of pancreatic exocrine dysfunction and gastrinoma, and to aid identification of the ampulla during ERCP.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Chirhostim, Secretin-Ferring
Drug type
Recombinant protein
Targets
Secretin receptor, CFTR (secondary target)
Mechanism
Agonist of Secretin receptor
Pathways
CFTR-mediated bicarbonate secretion, vagal-vagal neural pathway stimulation of pancreatic secretion
Therapy area
Oncology
Developer
Ferring
In trials of
RGEN
FDA status
Approved as Chirhostim, Secretin-Ferring, NDA018290 · FDA label
UNII
88C55N56UU

✅ FDA-approved uses

From the indications section of the FDA label (version of Oct 8, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00235274 Phase 2 Schizophrenia Completed RGEN
NCT01371240 Early Phase 1 Pancreas Cancer Withdrawn RGEN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Pancreas CancerSchizophrenia

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.